
|Articles|May 29, 2015
Dr Veena Shankaran Discusses Patient-Level Cancer Economics
Most of the research in cancer economics has been on total cost and cost effectiveness, which is why Veena Shankaran MD, MS, assistant professor in the division of medical oncology at the University of Washington, wanted to have a panel discussion on financial toxicity at the ISPOR 20th Annual Meeting.
Advertisement
Most of the research in cancer economics has been on total cost and cost effectiveness, which is why Veena Shankaran MD, MS, assistant professor in the division of medical oncology at the University of Washington, wanted to have a panel discussion on financial toxicity at the ISPOR 20th Annual Meeting.
The goal of the talk was to present strategies to measure financial burden and how to decrease the financial burden.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
2
COPD Deaths Rival Heart Failure, Exceed Prostate and Breast Cancer
3
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
4
COPERNICOS Trial: Eosinophil-Guided ICS Reduction Safe in COPD, Vestbo Says
5




